Trial Profile
Efficacy of Leflunomide on Joint Inflammation and Destruction of Joint Integrity in Active Rheumatoid Arthritis (RA) Patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Leflunomide (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Sanofi
- 09 Feb 2006 New trial record.